Zhejiang Medicine Co Ltd Strategic Asset Allocation Index
Zhejiang Medicine Co Ltd strategic asset allocation index. Zhejiang Medicine Co Ltd (600216) has a Strategic Asset Allocation Index of 56.5% as of June 2023. Strategic assets (PP&E of CN¥5.69 Billion plus long-term investments of CN¥-) total CN¥5.69 Billion, measured against net assets of CN¥10.07 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 600216 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Zhejiang Medicine Co Ltd (2000–2021)
Strategic asset allocation index of Zhejiang Medicine Co Ltd from 2000 to 2021. This chart shows how Zhejiang Medicine Co Ltd's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of June 2023, the index stands at 56.5%, representing strategic assets of CN¥5.69 Billion against net assets of CN¥10.07 Billion CNY. Check tangible net worth ratio of Zhejiang Medicine Co Ltd to evaluate the tangible quality of the company's equity base.
Zhejiang Medicine Co Ltd Strategic Asset Allocation Index by Year (2000–2021)
Zhejiang Medicine Co Ltd strategic asset allocation index by year from 2000 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Medicine Co Ltd from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Zhejiang Medicine Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 58.4% | CN¥5.36 Billion | CN¥5.36 Billion | CN¥- | CN¥9.18 Billion | ▲ +2.2 pp |
| 2020 | 56.2% | CN¥4.51 Billion | CN¥4.51 Billion | CN¥- | CN¥8.03 Billion | ▲ +2.2 pp |
| 2019 | 54.0% | CN¥4.46 Billion | CN¥4.46 Billion | CN¥- | CN¥8.25 Billion | ▼ -4.0 pp |
| 2018 | 58.1% | CN¥4.69 Billion | CN¥4.43 Billion | CN¥258.21 Million | CN¥8.08 Billion | ▼ -1.7 pp |
| 2017 | 59.8% | CN¥4.65 Billion | CN¥4.39 Billion | CN¥257.55 Million | CN¥7.78 Billion | ▼ -3.9 pp |
| 2016 | 63.6% | CN¥4.45 Billion | CN¥4.16 Billion | CN¥292.67 Million | CN¥6.99 Billion | ▼ -2.3 pp |
| 2015 | 65.9% | CN¥4.36 Billion | CN¥4.02 Billion | CN¥341.54 Million | CN¥6.62 Billion | ▲ +12.4 pp |
| 2014 | 53.5% | CN¥3.51 Billion | CN¥3.51 Billion | CN¥- | CN¥6.56 Billion | ▲ +5.1 pp |
| 2013 | 48.4% | CN¥3.14 Billion | CN¥3.14 Billion | CN¥- | CN¥6.48 Billion | ▲ +15.6 pp |
| 2012 | 32.8% | CN¥2.03 Billion | CN¥2.03 Billion | CN¥- | CN¥6.20 Billion | ▲ +0.0 pp |
| 2011 | 32.7% | CN¥1.44 Billion | CN¥1.44 Billion | CN¥- | CN¥4.40 Billion | ▼ -0.4 pp |
| 2010 | 33.1% | CN¥1.28 Billion | CN¥1.28 Billion | CN¥- | CN¥3.86 Billion | ▼ -9.3 pp |
| 2009 | 42.4% | CN¥1.21 Billion | CN¥1.21 Billion | CN¥- | CN¥2.86 Billion | ▼ -26.1 pp |
| 2008 | 68.5% | CN¥1.24 Billion | CN¥1.24 Billion | CN¥- | CN¥1.81 Billion | ▼ -73.7 pp |
| 2007 | 142.2% | CN¥1.24 Billion | CN¥1.24 Billion | CN¥- | CN¥873.73 Million | ▼ -9.2 pp |
| 2006 | 151.4% | CN¥1.18 Billion | CN¥1.18 Billion | CN¥- | CN¥777.31 Million | ▲ +13.0 pp |
| 2005 | 138.3% | CN¥1.01 Billion | CN¥1.01 Billion | CN¥- | CN¥732.23 Million | ▲ +27.9 pp |
| 2004 | 110.4% | CN¥712.87 Million | CN¥712.87 Million | CN¥- | CN¥645.68 Million | ▲ +4.0 pp |
| 2003 | 106.4% | CN¥668.98 Million | CN¥668.98 Million | CN¥- | CN¥628.48 Million | ▲ +2.9 pp |
| 2002 | 103.5% | CN¥652.04 Million | CN¥652.04 Million | CN¥- | CN¥629.71 Million | ▲ +19.2 pp |
| 2001 | 84.4% | CN¥513.40 Million | CN¥513.40 Million | CN¥- | CN¥608.50 Million | ▲ +24.6 pp |
| 2000 | 59.7% | CN¥379.43 Million | CN¥379.43 Million | CN¥- | CN¥635.03 Million | — |